Insider Trading activities of Idenix Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Idenix Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Idenix Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Idenix Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is IDIX. The reporting company's CIK number is 1093649.
The total value of stock buying since 2005 is $87,474,048.
The total value of stock sales since 2005 is $13,305,153.
The total value of stock option exercises since 2005 is $288,648.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Idenix Pharmaceuticals Inc (IDIX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2012-12 0 $0 0 $0 74,990 $201,348
2012-03 0 $0 30,000 $331,200 30,000 $72,300
2012-02 84,893 $338,468 0 $0 0 $0
2011-11 50,530 $199,138 0 $0 0 $0
2011-04 1,785,714 $4,999,999 0 $0 0 $0
2011-02 20,993 $76,204 0 $0 0 $0
2010-11 17,083 $63,685 0 $0 0 $0
2010-08 37,214 $113,502 0 $0 0 $0
2010-06 1,351 $3,255 0 $0 0 $0
2010-02 1,872 $4,511 0 $0 0 $0
2009-12 50,000 $105,755 0 $0 0 $0
2009-11 20,000 $37,800 0 $0 15,000 $15,000
2009-08 3,431 $8,268 0 $0 0 $0
2009-05 2,451 $6,421 0 $0 0 $0
2009-02 5,444 $13,120 0 $0 0 $0
2008-11 4,747 $19,225 0 $0 0 $0
2008-09 4,654 $13,636 0 $0 0 $0
2008-05 924 $2,226 0 $0 0 $0
2008-03 60,000 $133,500 0 $0 0 $0
2007-07 400 $1,536 0 $0 0 $0
2006-06 365 $7,475 0 $0 0 $0
2006-05 10,200 $93,152 0 $0 0 $0
2006-04 2,938 $47,683 0 $0 0 $0
2005-11 0 $0 629,498 $12,973,953 0 $0
2005-10 3,939,131 $81,185,489 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Idenix Pharmaceuticals Inc insiders (IDIX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-12-14 Renaud Ronald C Jr (President & CEO) Option Ex 74,990 2.68 201,348
2012-03-16 Fanning Paul (SVP, Human Resources) Sale 30,000 11.04 331,200
2012-03-16 Fanning Paul (SVP, Human Resources) Option Ex 30,000 2.41 72,300
2012-02-23 Novartis Pharma Ag (10% Owner) Buy 84,893 3.99 338,468
2011-11-22 Novartis Pharma Ag (10% Owner) Buy 50,530 3.94 199,138
2011-04-13 Novartis Pharma Ag (10% Owner) Buy 1,785,714 2.80 4,999,999
2011-02-25 Novartis Pharma Ag (10% Owner) Buy 20,993 3.63 76,204
2010-11-26 Novartis Pharma Ag (10% Owner) Buy 17,083 3.73 63,685
2010-08-23 Novartis Pharma Ag (10% Owner) Buy 37,214 3.05 113,502
2010-06-08 Novartis Pharma Ag (10% Owner) Buy 1,351 2.41 3,255
2010-02-26 Novartis Pharma Ag (10% Owner) Buy 1,872 2.41 4,511
2009-12-16 Hodgson Thomas R (Director) Buy 10,387 2.12 22,020
2009-12-15 Hodgson Thomas R (Director) Buy 15,000 2.15 32,250
2009-12-14 Hodgson Thomas R (Director) Buy 11,000 2.12 23,320
2009-12-11 Hodgson Thomas R (Director) Buy 8,613 2.08 17,915
2009-12-10 Hodgson Thomas R (Director) Buy 5,000 2.05 10,250
2009-11-24 Weidenbruch John (Ex. VP, Gen. Counsel and Secr.) Buy 20,000 1.89 37,800
2009-11-11 Standring David (EVP, Biology) Option Ex 15,000 1.00 15,000
2009-08-21 Novartis Pharma Ag (10% Owner) Buy 3,431 2.41 8,268
2009-05-29 Novartis Pharma Ag (10% Owner) Buy 2,451 2.62 6,421
2009-02-23 Novartis Pharma Ag (Other) Buy 5,444 2.41 13,120
2008-11-19 Novartis Pharma Ag (10% Owner) Buy 4,747 4.05 19,225
2008-09-02 Novartis Pharma Ag (10% Owner) Buy 4,654 2.93 13,636
2008-05-29 Novartis Pharma Ag (10% Owner) Buy 924 2.41 2,226
2008-03-11 Mayers Douglas L (EVP and Chief Medical Officer) Buy 30,000 4.45 133,500
2008-03-11 Renaud Ronald C Jr (Chief Financial Officer) Buy 15,000 .00 0
2008-03-11 Weidenbruch John (Ex. VP, Gen. Counsel and Secr.) Buy 15,000 .00 0
2007-07-13 Koppy Susan (Sr. VP, Business and Corp Dev.) Buy 400 3.84 1,536
2006-06-06 Novartis Pharma Ag (10% Owner) Buy 365 20.48 7,475
2006-05-09 Sommadossi Jean-pierre (President, CEO, Chairman) Buy 10,000 9.13 91,300
2006-05-08 Koppy Susan (Sr. VP, Business and Corp Dev.) Buy 200 9.26 1,852
2006-04-04 Novartis Pharma Ag (10% Owner) Buy 2,938 16.23 47,683
2005-11-14 Pollard-knight Denise (Director) Sale 629,498 20.61 12,973,953
2005-10-31 Novartis Pharma Ag (10% Owner) Buy 3,939,131 20.61 81,185,489

Insider trading activities including stock purchases, stock sales, and option exercises of IDIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Idenix Pharmaceuticals Inc (symbol IDIX, CIK number 1093649) see the Securities and Exchange Commission (SEC) website.